These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36892723)

  • 41. Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer.
    de Boer AZ; Bastiaannet E; de Glas NA; Marang-van de Mheen PJ; Dekkers OM; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Liefers GJ
    Breast Cancer Res Treat; 2019 Dec; 178(3):637-645. PubMed ID: 31451977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
    Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
    Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.
    Killander F; Karlsson P; Anderson H; Mattsson J; Holmberg E; Lundstedt D; Holmberg L; Malmström P
    Eur J Cancer; 2016 Nov; 67():57-65. PubMed ID: 27614164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omission of axillary sentinel lymph node biopsy in early invasive breast cancer.
    Reimer T
    Breast; 2023 Feb; 67():124-128. PubMed ID: 36658052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
    Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
    [No Abstract]   [Full Text] [Related]  

  • 48. Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis.
    Song YX; Xu Z; Liang MX; Liu Z; Hou JC; Chen X; Xu D; Fei YJ; Tang JH
    Cancer Med; 2022 Nov; 11(22):4085-4103. PubMed ID: 35502768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Neoadjuvant systemic therapy for breast cancer].
    Semiglazov VF
    Vopr Onkol; 2015; 61(2):162-8. PubMed ID: 26087591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
    Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
    Radiother Oncol; 2022 Sep; 174():37-43. PubMed ID: 35772577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation.
    de Boniface J; Frisell J; Bergkvist L; Andersson Y
    Br J Surg; 2018 Nov; 105(12):1607-1614. PubMed ID: 29926900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
    Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience.
    van der Noordaa MEM; Ioan I; Rutgers EJ; van Werkhoven E; Loo CE; Voorthuis R; Wesseling J; van Urk J; Wiersma T; Dezentje V; Vrancken Peeters MTFD; van Duijnhoven FH
    Ann Surg Oncol; 2021 Nov; 28(12):7383-7394. PubMed ID: 33978889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response.
    Mandish SF; Gaskins JT; Yusuf MB; Amer YM; Eldredge-Hindy H
    Acta Oncol; 2020 Oct; 59(10):1210-1217. PubMed ID: 32716227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
    Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
    Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.
    Boér K; Kahán Z; Landherr L; Csőszi T; Máhr K; Ruzsa Á; Horváth Z; Budai B; Rubovszky G
    Pathol Oncol Res; 2021; 27():1609785. PubMed ID: 34257621
    [No Abstract]   [Full Text] [Related]  

  • 57. Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study.
    Corradini S; Niyazi M; Niemoeller OM; Li M; Roeder F; Eckel R; Schubert-Fritschle G; Scheithauer HR; Harbeck N; Engel J; Belka C
    Radiother Oncol; 2015 Jan; 114(1):28-34. PubMed ID: 25236715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
    Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
    Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX).
    de Wild SR; Simons JM; Vrancken Peeters MTFD; Smidt ML; Koppert LB;
    Clin Breast Cancer; 2022 Jan; 22(1):e59-e64. PubMed ID: 34446364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current and future role of neoadjuvant therapy for breast cancer.
    Untch M; Konecny GE; Paepke S; von Minckwitz G
    Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.